In Vivo Pharmacology Services

Translational In Vivo Pharmacology Studies

Evaluating complex physiological responses in living organisms is essential to confirming candidate efficacy and safety. WuXi Biology and Testing delivers comprehensive in vivo pharmacology studies to assess therapeutic performance, mechanism of action, and early toxicity across small molecules and biologics.

Combining deep preclinical expertise with extensive disease model platforms, our team provides the reliable data and insights needed to advance your pipeline toward clinical success across all therapeutic areas.

Preclinical Integrated Services

We combine in vitro biology, PK/PD, and early toxicology studies to generate comprehensive datasets that enable confident lead selection and successful IND filings.

Our scientific teams provide tailored drug discovery solutions across multiple therapeutic areas — including oncology, immunology, infectious disease, neuroscience, fibrosis, and cardiovascular/metabolic diseases. Leveraging advanced technology platforms and deep domain expertise, we work collaboratively to rapidly propel your programs from initial target validation through preclinical candidate selection and beyond.

Assays and Tests

Specialized In Vivo Pharmacology Capabilities

Explore our comprehensive collection of translational in vivo disease models across 10 key therapeutic areas to support candidate selection and IND-enabling studies.

In Vivo Pharmacology Webinars & More

Rare Disease Therapeutics: Accelerating Development and Improving Access

Trends in Rare Disease Drug Development

Translational Pharmacology of CNS and Metabolic Disorders for Testing New Modality Therapies

Explore Solutions

Explore Solutions for Your Program

Explore solutions by development phase, drug modality, therapeutic area, or integrated discovery needs.

Get A Quote

Get a Quote

Ready to plan your next study? Share your program needs with our team for a tailored estimate.

Get a Quote